Mark Jones - Abingdon Health Chief Officer
| ABDX Stock | 7.25 0.25 3.57% |
Insider
Mark Jones is Chief Officer of Abingdon Health Plc
| Address | York Biotech Campus, York, United Kingdom, YO41 1LZ |
| Phone | 44 19 0440 6050 |
| Web | https://www.abingdonhealth.com |
Mark Jones Latest Insider Activity
Tracking and analyzing the buying and selling activities of Mark Jones against Abingdon Health stock is an integral part of due diligence when investing in Abingdon Health. Mark Jones insider activity provides valuable insight into whether Abingdon Health is net buyers or sellers over its current business cycle. Note, Abingdon Health insiders must abide by specific rules, including filing SEC forms every time they buy or sell Abingdon Health'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Mark Jones few days ago Acquisition by Mark Jones of 10418 shares of Goosehead Insurance at 10.0 subject to Rule 16b-3 | ||
Mark Jones over six months ago Disposition of 500 shares by Mark Jones of Goosehead Insurance subject to Rule 16b-3 | ||
Mark Jones over six months ago Disposition of 8977 shares by Mark Jones of Goosehead Insurance at 10.0 subject to Rule 16b-3 | ||
Mark Jones over six months ago Disposition of 11699 shares by Mark Jones of Goosehead Insurance at 10.0 subject to Rule 16b-3 |
Abingdon Health Management Efficiency
The company has return on total asset (ROA) of (0.1793) % which means that it has lost $0.1793 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.4869) %, meaning that it generated substantial loss on money invested by shareholders. Abingdon Health's management efficiency ratios could be used to measure how well Abingdon Health manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Abingdon Health's Total Assets are comparatively stable compared to the past year. Intangible Assets is likely to gain to about 969 K in 2025, whereas Total Current Assets are likely to drop slightly above 3.4 M in 2025. Abingdon Health Plc (ABDX) is traded on London Exchange in UK and employs 84 people. Abingdon Health is listed under Biotechnology category by Fama And French industry classification.Management Performance
| Return On Equity | -0.49 | ||||
| Return On Asset | -0.18 |
Abingdon Health Plc Leadership Team
Elected by the shareholders, the Abingdon Health's board of directors comprises two types of representatives: Abingdon Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Abingdon. The board's role is to monitor Abingdon Health's management team and ensure that shareholders' interests are well served. Abingdon Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Abingdon Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Chris Yates, CEO Director | ||
| Mark Jones, Chief Officer | ||
| Melanie Ross, Company CFO | ||
| Nina Garrett, Head Devel | ||
| Oliver Gardner, Chief Officer | ||
| Laura Towse, Group Controller | ||
| Christopher Hand, Executive Chairman | ||
| Brenda Hogan, HR Director | ||
| Thomas Hayes, CFO Director |
Abingdon Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Abingdon Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.49 | ||||
| Return On Asset | -0.18 | ||||
| Profit Margin | (0.21) % | ||||
| Operating Margin | (0.04) % | ||||
| Current Valuation | 13.35 M | ||||
| Shares Outstanding | 189.52 M | ||||
| Shares Owned By Insiders | 47.92 % | ||||
| Shares Owned By Institutions | 33.31 % | ||||
| Price To Book | 6.11 X | ||||
| Price To Sales | 2.24 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Abingdon Stock Analysis
When running Abingdon Health's price analysis, check to measure Abingdon Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abingdon Health is operating at the current time. Most of Abingdon Health's value examination focuses on studying past and present price action to predict the probability of Abingdon Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abingdon Health's price. Additionally, you may evaluate how the addition of Abingdon Health to your portfolios can decrease your overall portfolio volatility.